Day: June 9, 2020

ROVIO ENTERTAINMENT OYJLisätietoja:Rene Lindell, talousjohtajarene.lindell@rovio.com+358 40 485 8985Jakelu:Nasdaq Helsinki LtdKeskeiset tiedotusvälineethttps://investors.rovio.com/fiRovio lyhyesti:Rovio Entertainment Oyj on maailmanlaajuinen, peleihin keskittyvä viihdeyhtiö, joka luo, kehittää ja julkaisee mobiilipelejä, joita on jo tähän mennessä ladattu jo yli 4,5 miljardia kertaa. Rovio tunnetaan parhaiten Angry Birds -brändistään, joka sai alkunsa mobiilipelistä vuonna 2009 ja on sittemmin peleistä lisensointinsa kautta laajentunut erilaisiin viihde- ja kuluttajatuotekategorioihin. Rovio tarjoaa useita mobiilipelejä, animaatioita ja on tuottanut Angry Birds -elokuvan vuonna 2016, ja elokuvan jatko-osa, Angry Birds -elokuva 2 julkaistiin 2019. Rovion pääkonttori on Espoossa ja yhtiö on listattu NASDAQ Helsingin päälistalla tunnuksella...

ROVIO ENTERTAINMENT CORPORATIONMore information:Rene Lindell, CFOrene.lindell@rovio.com+358 40 485 8985Distribution:Nasdaq Helsinki LtdKey mediahttps://investors.rovio.com/enAbout Rovio:Rovio Entertainment Corporation is a global, games-first entertainment company that creates, develops and publishes mobile games, which have been downloaded over 4.5 billion times so far. Rovio is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainment and consumer products in brand licensing. Today, Rovio offers multiple mobile games, animations and produced The Angry Birds Movie in 2016. Its sequel, The Angry Birds Movie 2, was released in 2019. Rovio is headquartered in Finland and the company’s shares are listed on the main list of NASDAQ Helsinki stock...

ROVIO ENTERTAINMENT OYJLisätietoja:Rene Lindell, talousjohtajarene.lindell@rovio.com+358 40 485 8985Jakelu:Nasdaq Helsinki LtdKeskeiset tiedotusvälineethttps://investors.rovio.com/fiRovio lyhyesti:Rovio Entertainment Oyj on maailmanlaajuinen, peleihin keskittyvä viihdeyhtiö, joka luo, kehittää ja julkaisee mobiilipelejä, joita on jo tähän mennessä ladattu jo yli 4,5 miljardia kertaa. Rovio tunnetaan parhaiten Angry Birds -brändistään, joka sai alkunsa mobiilipelistä vuonna 2009 ja on sittemmin peleistä lisensointinsa kautta laajentunut erilaisiin viihde- ja kuluttajatuotekategorioihin. Rovio tarjoaa useita mobiilipelejä, animaatioita ja on tuottanut Angry Birds -elokuvan vuonna 2016, ja elokuvan jatko-osa, Angry Birds -elokuva 2 julkaistiin 2019. Rovion pääkonttori on Espoossa ja yhtiö on listattu NASDAQ Helsingin päälistalla tunnuksella...

ROVIO ENTERTAINMENT CORPORATIONMore information:Rene Lindell, CFOrene.lindell@rovio.com+358 40 485 8985Distribution:Nasdaq Helsinki LtdKey mediahttps://investors.rovio.com/enAbout Rovio:Rovio Entertainment Corporation is a global, games-first entertainment company that creates, develops and publishes mobile games, which have been downloaded over 4.5 billion times so far. Rovio is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainment and consumer products in brand licensing. Today, Rovio offers multiple mobile games, animations and produced The Angry Birds Movie in 2016. Its sequel, The Angry Birds Movie 2, was released in 2019. Rovio is headquartered in Finland and the company’s shares are listed on the main list of NASDAQ Helsinki stock...

ROVIO ENTERTAINMENT OYJLisätietoja:Rene Lindell, talousjohtajarene.lindell@rovio.com+358 40 485 8985Jakelu:Nasdaq Helsinki LtdKeskeiset tiedotusvälineethttps://investors.rovio.com/fiRovio lyhyesti:Rovio Entertainment Oyj on maailmanlaajuinen, peleihin keskittyvä viihdeyhtiö, joka luo, kehittää ja julkaisee mobiilipelejä, joita on jo tähän mennessä ladattu jo yli 4,5 miljardia kertaa. Rovio tunnetaan parhaiten Angry Birds -brändistään, joka sai alkunsa mobiilipelistä vuonna 2009 ja on sittemmin peleistä lisensointinsa kautta laajentunut erilaisiin viihde- ja kuluttajatuotekategorioihin. Rovio tarjoaa useita mobiilipelejä, animaatioita ja on tuottanut Angry Birds -elokuvan vuonna 2016, ja elokuvan jatko-osa, Angry Birds -elokuva 2 julkaistiin 2019. Rovion pääkonttori on Espoossa ja yhtiö on listattu NASDAQ Helsingin päälistalla tunnuksella...

BERKELEY, Calif. and VANCOUVER, British Columbia, June 09, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce that Dr. Bill Williams, BriaCell’s President & CEO, has been invited to present at 3rd Annual Next-Gen Immuno-Oncology Congress, a virtual event, will be held on June 25 – 26, 2020.Details of BriaCell’s oral presentation are the following:Event: 3rd Annual Next-Gen Immuno-Oncology CongressDate: June 26, 2020Time: 9:30 Eastern TimeTitle: Cancer Immunotherapy: A Targeted, Personalized and Off-the-Shelf ApproachSession: Stream B, Immune Checkpoint Inhibitors, Immune Modulating Agents & Tumor Micro-EnvironmentFollowing the presentations,...

IRVINE, Calif., June 09, 2020 (GLOBE NEWSWIRE) — CorVel Corporation, a national provider of risk management solutions, today announced the expansion of case management resources and virtual tools to support injured workers throughout COVID-19 as well as to assist organizations as they transition back to the workplace.As the pandemic continues to evolve, CorVel has expanded case management tools and resources to facilitate better care for injured workers, including:Virtual wellness checks by nurse case managers to mitigate anxiety and ensure precautionary measures are followed to prevent COVID-19 exposure.Transfer of care to virtual physical therapy and virtual cognitive therapy to allow progress to continue.Home delivery of prescriptions, which case managers coordinate with CorVel’s certified pharmacy technicians to ensure all medications...

SAN CARLOS, Calif., June 09, 2020 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cybersecurity solutions globally, has today released the findings of a new survey showing how organizations managed their cyber-security during the lockdowns forced by the Covid-19 pandemic, and also listing their security priorities and concerns over the coming months as they move to the ‘new normal.’Over 86% of respondents said their biggest IT challenge during the pandemic was moving to mass remote working, and their biggest security concern was maintaining VPN capacity for staff.  Key findings from the survey of over 270 IT and security professionals globally are:Top security concerns at the start of Covid-19 lockdowns:  62% of respondents said their main concern during initial lockdowns was maintaining...

RANCHO CUCAMONGA, Calif., June 09, 2020 (GLOBE NEWSWIRE) — Amphastar® Pharmaceuticals, Inc., (NASDAQ: AMPH) (“Amphastar”), today announces that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial. Amphastar’s newly approved drug product was determined by the FDA to be therapeutically equivalent to Quelicin™ (Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial) distributed in the United States by Pfizer, Inc. Succinylcholine Chloride Injection is for intramuscular and intravenous use. It is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.Amphastar’s...